2024
DOI: 10.1042/bsr20231385
|View full text |Cite
|
Sign up to set email alerts
|

Anorexigenic neuropeptides as anti-obesity and neuroprotective agents

Veronika Strnadová,
Andrea Pačesová,
Vilém Charvát
et al.

Abstract: Since 1975, the incidence of obesity has increased to epidemic proportions, and the number of patients with obesity has quadrupled. Obesity is a major risk factor for developing other serious diseases, such as type 2 diabetes mellitus, hypertension, and cardiovascular diseases. Recent epidemiologic studies have defined obesity as a risk factor for the development of neurodegenerative diseases, such as Alzheimer's disease (AD) and other types of dementia. Despite all these serious comorbidities associated with … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 261 publications
0
0
0
Order By: Relevance